Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
letter
. 1981 Sep 1;125(5):422–424.

Bacteroides fragilis septicemia during cefamandole therapy.

J Righter
PMCID: PMC1862477  PMID: 7284925

Full text

PDF
422

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chow A. W., Bednorz D. Comparative in vitro activity of newer cephalosporins against anaerobic bacteria. Antimicrob Agents Chemother. 1978 Nov;14(5):668–671. doi: 10.1128/aac.14.5.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ernst E. C., Berger S., Barza M., Jacobus N. V., Tally F. P. Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria. Antimicrob Agents Chemother. 1976 May;9(5):852–855. doi: 10.1128/aac.9.5.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Greenberg R. N., Scalcini M. C., Sanders C. V., Lewis A. C. Cefamandole therapy in anaerobic infections. Antimicrob Agents Chemother. 1979 Mar;15(3):337–341. doi: 10.1128/aac.15.3.337. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES